Osaic Holdings’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,400
Closed -$4K 7834
2022
Q2
$4K Buy
+1,400
New +$5.45K ﹤0.01% 6680
2022
Q1
Sell
-1,150
Closed -$5K 7863
2021
Q4
$5K Sell
1,150
-1,350
-54% -$5.63K ﹤0.01% 6716
2021
Q3
$10K Sell
2,500
-250
-9% -$992 ﹤0.01% 6258
2021
Q2
$12K Sell
2,750
-1,000
-27% -$4.28K ﹤0.01% 5986
2021
Q1
$16K Sell
3,750
-1,825
-33% -$10.1K ﹤0.01% 5643
2020
Q4
$21K Sell
5,575
-1,600
-22% -$6.84K ﹤0.01% 5146
2020
Q3
$29K Sell
7,175
-1,375
-16% -$5.7K ﹤0.01% 4699
2020
Q2
$37K Sell
8,550
-15,370
-64% -$93.6K ﹤0.01% 4414
2020
Q1
$101K Buy
+23,920
New +$151K ﹤0.01% 3473

Osaic Holdings's LJPC Position: Q3 2022 in Review

Osaic Holdings sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 1,400 shares — an estimated $4K sold.

Osaic Holdings first reported a position in LJPC in Q1 2020 and held it in 9 quarters. The position peaked at $101K in Q1 2020. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

  • Osaic Holdings reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
  • Osaic Holdings sold 1,400 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $4K.
  • Osaic Holdings first reported a position in La Jolla Pharmaceutical Company in Q1 2020 and held it in 9 quarters.
  • Osaic Holdings's La Jolla Pharmaceutical Company position peaked at $101K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.